MAZE logo

Maze Therapeutics, Inc. (MAZE) Depreciation & Amortization

Annual D&A:

$3.30M-$792.00K(-19.37%)
December 31, 2024

Summary

  • As of today, MAZE annual D&A is $3.30 million, with the most recent change of -$792.00 thousand (-19.37%) on December 31, 2024.
  • During the last 3 years, MAZE annual D&A has fallen by -$523.00 thousand (-13.69%).
  • MAZE annual D&A is now -19.37% below its all-time high of $4.09 million, reached on December 31, 2023.

Performance

MAZE Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

Quarterly D&A:

$571.00K-$78.00K(-12.02%)
September 30, 2025

Summary

  • As of today, MAZE quarterly D&A is $571.00 thousand, with the most recent change of -$78.00 thousand (-12.02%) on September 30, 2025.
  • MAZE quarterly D&A is now -81.66% below its all-time high of $3.11 million, reached on September 1, 2023.

Performance

MAZE Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

TTM D&A:

$2.61M+$571.00K(+28.02%)
September 30, 2025

Summary

  • As of today, MAZE TTM D&A is $2.61 million, with the most recent change of +$571.00 thousand (+28.02%) on September 30, 2025.
  • MAZE TTM D&A is now -48.22% below its all-time high of $5.04 million, reached on March 1, 2024.

Performance

MAZE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

MAZE Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-19.4%--
3Y3 Years-13.7%-81.7%-16.2%
5Y5 Years-13.7%-81.7%-16.2%

MAZE Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-19.4%at low-81.7%at low-48.2%+87.8%
5Y5-Year-19.4%at low-81.7%at low-48.2%+87.8%
All-TimeAll-Time-19.4%at low-81.7%at low-48.2%+87.8%

MAZE Depreciation & Amortization History

DateAnnualQuarterlyTTM
Sep 2025
-
$571.00K(-12.0%)
$2.61M(+28.0%)
Jun 2025
-
$649.00K(-5.1%)
$2.04M(+46.7%)
Mar 2025
-
$684.00K(-3.0%)
$1.39M(-16.1%)
Dec 2024
$3.30M
$705.00K(-25.8%)
$1.66M(-67.2%)
DateAnnualQuarterlyTTM
Mar 2024
-
$950.00K(-2.7%)
$5.04M(+23.2%)
Dec 2023
$4.09M(+7.0%)
$976.00K(-68.6%)
$4.09M(+31.4%)
Sep 2023
-
$3.11M
$3.11M
Dec 2022
$3.82M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual D&A?
  • What is the all-time high annual D&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual D&A year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly D&A?
  • What is the all-time high quarterly D&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM D&A?
  • What is the all-time high TTM D&A for Maze Therapeutics, Inc.?

What is Maze Therapeutics, Inc. annual D&A?

The current annual D&A of MAZE is $3.30M

What is the all-time high annual D&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual D&A is $4.09M

What is Maze Therapeutics, Inc. annual D&A year-on-year change?

Over the past year, MAZE annual D&A has changed by -$792.00K (-19.37%)

What is Maze Therapeutics, Inc. quarterly D&A?

The current quarterly D&A of MAZE is $571.00K

What is the all-time high quarterly D&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly D&A is $3.11M

What is Maze Therapeutics, Inc. TTM D&A?

The current TTM D&A of MAZE is $2.61M

What is the all-time high TTM D&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM D&A is $5.04M
On this page